Reconsidering Caffeine: An Awake and Alert New Look at America's Most Commonly Consumed Drug

DSpace/Manakin Repository

Reconsidering Caffeine: An Awake and Alert New Look at America's Most Commonly Consumed Drug

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Mrazik, David M. en_US
dc.date.accessioned 2012-06-07T04:38:05Z
dc.date.issued 2004 en_US
dc.identifier.citation Reconsidering Caffeine: An Awake and Alert New Look at America's Most Commonly Consumed Drug (2004 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846793
dc.description.abstract Caffeine is one of the most pervasively ingested addictive substances in the United States, yet astoundingly little attention is paid to its ubiquitous presence. This Paper examines caffeine, the substance, from many perspectives. First, it discusses caffeine with particular regard to its chemical properties; its presence in foods, beverages, and medications both naturally and as an additive; and its known impacts on human biological and psychological functioning. Relevant medical investigations of caffeine’s therapeutic properties and its toxicology are included in order to better evaluate the benefits, the risks, and the relative safety of prolonged caffeine consumption. In light of more recent medical findings, the Paper finds that caffeine poses fewer serious health risks than previously thought, and the potential for damage to the vast majority of the consumer public is minimal. The Paper also addresses issues of FDA regulation of caffeine, including a discussion of current regulation and classification of the substance both as a food product and as a drug product, as well as questioning the usefulness of greater consumer warning labels and promotion of improved public awareness of caffeine’s various health effects. Due to both the paucity of long-term caffeine health studies and the conflicts among those studies, the Paper contends that heightened FDA regulatory scrutiny of American caffeine consumption is an unnecessary expenditure of limited resources. The Paper finds caffeine poses no material danger to the consumer, and dismisses the claims of prior authors to that effect as generally overstated. Finally, the Paper poses a hypothetical analysis of caffeine as both a new food additive and a new drug, in order to illustrate the FDA’s modern regulatory process and demonstrate greater confidence in the safety of consumer caffeine use. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject caffeine en
dc.subject FDA en
dc.subject regulation en
dc.title Reconsidering Caffeine: An Awake and Alert New Look at America's Most Commonly Consumed Drug en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T04:38:05Z

Files in this item

Files Size Format View
Mrazik.pdf 381.8Kb PDF View/Open
Mrazik.rtf 235.3Kb RTF file View/Open
Mrazik.html 236.0Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters